Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-11

Clinical Trial Update: Good EULAR Response In Patients With Early Rheumatoid Arthritis

View source ↗

Summary

Pfizer-sponsored clinical trial in early rheumatoid arthritis reports a good EULAR response and has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-11-11